Unverified50% confidenceFactExact time

The coverage of the IGSC screening protocol is limited, and non-member companies, academic laboratories, and overseas synthesizers are not bound by it.

1

Sources

50%

Confidence

Medium-term (~90 days)

Relevance

9/18/2026

First Seen

Valid until: 12/17/2026

Sources

The Emerging Risk of AI-Enabled Bioweapons: A Wake-Up Call for the Biotech Industry

Related Entities

Related Claims

VerifiedThe current AI safety assessment mechanism has yet to form a mandatory review process with legal binding force, and relies more on voluntary cooperation from vendors.60% similar UnverifiedThe regulatory standards for chimera research are not uniform across countries.59% similar

Cite This Claim

Stable URI

https://kongchang.com/claim/931700

API

curl https://kongchang.com/api/v1/knowledge/claims/931700

MCP

get_claim(id=931700)